Shanghai Haoyuan Chemexpress (688131.SH) has received approval from the China Securities Regulatory Commission to issue convertible bonds.

date
16:56 23/09/2024
avatar
GMT Eight
Hao Yuan Pharmaceuticals (688131.SH) announced that the company received a notice from the China Securities Regulatory Commission on September 21, 2024...
Shanghai Haoyuan Chemexpress (688131.SH) announced that on September 21, 2024, the company received approval from the China Securities Regulatory Commission for the registration of the issuance of convertible bonds to unspecified investors. The approval allows the company to proceed with the application to issue convertible bonds to unspecified investors.